Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Anika Therapeutics (NQ: ANIK ) 24.27 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Anika Therapeutics < Previous 1 2 Next > ANIK Stock Earnings: Anika Therapeutics Beats EPS, Misses Revenue for Q2 2024 August 08, 2024 ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights May 29, 2024 Via Benzinga ANIK Stock Earnings: Anika Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 ANIK stock results show that Anika Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Anika Therapeutics: Q4 Earnings Insights March 13, 2024 Via Benzinga Earnings Outlook For Anika Therapeutics March 12, 2024 Via Benzinga Airbnb, Blackstone Rise On News They'll Join S&P 500 Index September 02, 2023 ABNB and BX will join Sept. 18 as part of a quarterly rebalancing. Via Investor's Business Daily Topics Stocks Exposures US Equities Recap: Anika Therapeutics Q1 Earnings May 09, 2023 Via Benzinga Anika Therapeutics Earnings Preview March 03, 2023 Via Benzinga Earnings Scheduled For March 13, 2024 March 13, 2024 Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million. Via Benzinga 3 Sorry Penny Stocks to Sell in August Before It’s Too Late August 22, 2023 As interest rates rise and money becomes more expensive, investors may look to get rid of these penny stocks set to fail. Via InvestorPlace New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio May 20, 2022 Via Benzinga Stocks That Hit 52-Week Lows On Friday March 11, 2022 During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest... Via Benzinga Stocks That Hit 52-Week Lows On Friday February 04, 2022 On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... Via Benzinga The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO August 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023 August 14, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023 March 07, 2023 Via Benzinga 7 Stocks to Buy Before the Market Starts to Soar in 2023 November 10, 2022 With the market falling into a bit of disarray, astute investors can leverage this moment to dive into compelling stocks to buy. Via InvestorPlace Anika Therapeutics Cingal Tops Steroid For Osteoarthritis Pain Relief November 01, 2022 Via Benzinga Anika Therapeutics: Q2 Earnings Insights August 03, 2022 Anika Therapeutics (NASDAQ:ANIK) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday March 09, 2022 During Wednesday's session, 35 companies made new 52-week lows. 52-Week High And Low Highlights: The company with the largest market cap to set a new 52-week low was... Via Benzinga Anika Therapeutics: Q4 Earnings Insights March 08, 2022 Anika Therapeutics (NASDAQ:ANIK) reported its Q4 earnings results on Tuesday, March 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings... Via Benzinga The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout March 08, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... Via Benzinga Anika Therapeutics, inc (ANIK) Q3 2021 Earnings Call Transcript November 05, 2021 ANIK earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Return on Capital Employed Insights for Anika Therapeutics August 23, 2021 After pulling data from Benzinga Pro it seems like during Q2, Anika Therapeutics (NASDAQ:ANIK) earned $9.18 million, a 629.73% increase from the preceding quarter. Anika... Via Benzinga Anika Therapeutics, inc (ANIK) Q2 2021 Earnings Call Transcript August 06, 2021 ANIK earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Earnings Scheduled For March 8, 2022 March 08, 2022 Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... Via Benzinga The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg March 06, 2022 Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... Via Benzinga Stocks That Hit 52-Week Lows On Thursday February 03, 2022 On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2021 November 16, 2021 Upgrades According to Maxim Group, the prior rating for VirTra Inc (NASDAQ: Via Benzinga The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs August 01, 2021 Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... Via Benzinga Exposures Product Safety < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.